Haemophilus influenzae type b and pertussis vaccinations in preterm infants

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 3, 2006, Pages 193-199

  Sikora, Janusz Piotr ^a   Chlebna Sokół, Danuta ^a   Ligenza, Iwona ^a   Sikora, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hib; Pertussis; Preterm infants; Vaccination

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; RIBITOL; RIBOSE;

ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; DRUG EFFICACY; ENZYME IMMUNOASSAY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; POLAND; PREMATURITY; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; GESTATIONAL AGE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT, NEWBORN; INFANT, PREMATURE; VACCINES, CONJUGATE;

EID: 33747520025     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0020-4     Document Type: Article

References (25)

1. Adderson E. E. (2001): Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin. Immunopathol., 23, 387-403.
2. CDC (1997): Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mort. Wkly. Rep., 46 (RR-7), 1-25.
3. Cochi S. L., Fleming D. W. and Hightower A. W. (1986): Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J. Pediatr., 108, 887-896.
4. Committee on Infectious Diseases American Academy of Pediatrics (1997): Pertussis. In Peter G., Hall C. B., Halsey N. A., Marcy S. M., Pickering L. K. and Orenstein W. A. (eds.): Report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL, USA, 394-406.
5. Crowley-Luke A., Reddin K., Gorringe A., Hudson M. J. and Robinson A. (2001): Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines. Vaccine, 19, 3399-3407.
6. Dawson K. G., Emerson J. C. and Burns J. L. (1999): Fifteen years of experience with bacterial meningitis. Pediatr. Infect. Dis. J., 18, 816-822.
7. Esposito S., Faldella G., Giammanco A., Bosis S., Friscia O., Clerici M. and Principi N. (2002): Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in preterm infants. Vaccine, 20, 2928-2932.
8. Gała̧zka A. (1998): Diseases caused by Haemophilus influenzae type b (Hib). I. Epidemiology and health significance of Hib diseases. Przegl. Pediatr., 28, 93-98.
9. Granoff D. M. (2001): Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clin. Infect. Dis., 33 (suppl. 4), S278-287.
10. Heath P. T., Booy R., Griffiths H., Clutterbuck E., Azzopardi H. J., Slack M. P., Fogarty J., Moloney A. C. and Moxon E. R. (2000): Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin. Infect. Dis., 31, 973-980.
11. Heath P. T., Booy R., McVernon J., Bowen-Morris J., Griffiths H., Slack M. P., Moloney A. C., Ramsay M. E. and Moxon E. R. (2003): Hib vaccination in infants born prematurely. Arch. Dis. Child., 88, 206-210.
12. Hussey G., Malan H., Hughes J., Eley B., Piollet M., Charrondiere M. and Sachs E. (2002): Safety and immunogenicity of TERTActHIB (a vaccine combining DTP vaccine and Haemophilus influenzae type B conjugate vaccine) administered to infants at 6, 10, and 14 weeks of age. S. Afr. Med. J., 92, 53-57.
13. Kamboj K. K., King C. L., Greenspan N. S., Kirchner H. L. and Schreiber J. R. (2001): Immunization with Haemophilus influenzae type b-CRM (197) conjugate vaccine elicits a mixed Th1 and Th2 CD (4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. J. Infect. Dis., 184, 931-935.
14. Khalak R., Pichichero M. E. and D'Angio C. T. (1998): Three-year follow-up of vaccine response in extremely preterm infants. Pediatrics, 101 (4 Pt 1), 597-603.
15. Kirmani K. I., Lofthus G., Pichichero M. E., Voloshen T. and D'Angio C. T. (2002): Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics, 109, 498-504.
16. Kristensen K., Gyhrs A., Lausen B., Barington T. and Heilmann C. (1996): Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr. Infect. Dis. J., 15, 525-529.
17. Musser J. M., Granoff D. M., Pattison P. E. and Selander R. K. (1985): A population genetic framework for the study of invasive disease caused by serotype b strains of Haemophilus influenzae. Proc. Natl. Acad. Sci. USA, 82, 5078-5082.
18. Patrzałek M. and Natwora-Goła̧bek B. (1997): Etiologic factors for purulent meningitis in children. Twenty years of personal observations. Przegl. Epidemiol., 51, 303-307.
19. Poland G. A. (1997): Still more questions on pertussis vaccines. Lancet, 350, 1564-1565.
20. Saari T. N. and American Academy of Pediatrics Committee on Infectious Diseases (2003): Immunization of preterm and low birth weight infants. Pediatrics, 112 (Pt 1), 193-198.
21. Schloesser R. L., Fischer D., Otto W., Rettwitz-Volk W., Herden P. and Zielen S. (1999): Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics, 103, e60.
22. Slack M. H., Schapira D., Thwaites R. J., Burrage M., Southern J., Goldblatt D. and Miller E. (2004): Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. Arch. Dis. Child Fetal Neonatal Ed., 89, F269-271.
23. Szenborn L., Banyś D., Żarczynska H., Pejcz J., Kołomyjec A. and Rudkowski Z. (1998): Rate of nasopharyngeal colonisation with Haemophilus influenzae type b in infants and children as a basis of immunization. Przegl. Epidemiol., 52 (suppl. 1), S39-42.
24. Tomaszunas-Błaszczyk J. (1999): Pertussis in 1997. Przegl. Epidemiol., 53, 23-32.
25. Zieliński A. (2001): Epidemiological assessment of an effectiveness of vaccinations. Przegl. Epidemiol., 55, 197-205.